| Date | Form | Description | Docs | XBRL | Pages |
| 09/30/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/29/22 | 8-K | Current report filing |
|
|
14 |
| 09/19/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 09/14/22 | UPLOAD | SEC-generated letter |
|
1 | |
| 09/12/22 | DEL AM | Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement |
|
1 | |
| 09/09/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
68 | |
| 09/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
21 |
Latest News & Events
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Read More...